NFKB1 and cancer: As hypothesized for Curcumin, it could be that the great efficacy of bDHC in tumor cells is caused by (i) their lower glutathione levels, which enhances drug sensitivity compared to normal cells or (ii) the constitutive expression of active NF-kB in cancer cells, which is one of Curcuminoids targets [67].